Carmenta Bioscience Receives $2,000,000 Seed Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8c4ec938-9bcd-4571-a488-4cf472cc0174
Date
8/8/2013
Company Name
Carmenta Bioscience
Mailing Address
4240 Wilkie Way Palo Alto, CA 94306
Company Description
Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.
Website
http://www.carmentabio.com
Transaction Type
Venture Equity
Transaction Amount
$2,000,000
Transaction Round
Seed
Proceeds Purposes
Proceeds from the financing will support development and commercialization of a new, proprietary test to better diagnose and predict preeclampsia in pregnant women.
M&A Terms
Venture Investor
Investor